Uribe Jesus,  Goodarzian Fariba

Final Pr. ID: Poster #: SCI-031

Gadoxetate disodium-enhanced MRI abdomen is the imaging of choice for evaluation of liver lesions. However, in patients with underlying liver dysfunction, uptake and excretion of the hepatobiliary contrast agent is impaired; standard 20-minute delay hepatobiliary phase imaging may be insufficient to characterize hepatic lesions of interest. Our study aims to evaluate the adequacy of standard 20-minute delayed phase hepatobiliary imaging after gadoxetate disodium administration in pediatric patients with liver dysfunction. A secondary objective is to assess the utility of hepatic function laboratory values as a screening tool to identify patients with impaired hepatobiliary excretion in whom hepatobiliary phase imaging at 20 minutes may be inadequate. Read More

Authors:  Uribe Jesus , Goodarzian Fariba

Keywords:  Liver, Eovist, Fontan

Md, Mph Eric,  Richer Edward,  Strouse Peter,  Smith Ethan

Final Pr. ID: Poster #: SCI-053

Focal nodular hyperplasia (FNH) is a benign lesion. Gadoxetate disodium (Eovist), a hepatocyte specific contrast agent, is becoming more widely used in pediatric MR imaging. FNH is composed of hepatocytes and should demonstrate homogeneous enhancement on the hepatobiliary phase of imaging; however, in clinical practice a variety of enhancement patterns have been observed. The purpose of this study is to document the features of FNH on hepatobiliary phase MRI in pediatric patients. Read More

Authors:  Md, Mph Eric , Richer Edward , Strouse Peter , Smith Ethan

Keywords:  FNH, focal nodular hyperplasia, Eovist, gadoxetate disodium